| 34.76 Delayed Data As of 4:10pm ET |  -1.25 / -3.47%Today’s Change | 21.35 Today|||52-Week Range 53.80 | -24.60% Year-to-Date |
The investment seeks daily investment results- before fees and expenses- of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund- under normal circumstances- invests in swap agreements- futures contracts- short positions or other financial instruments that- in combination- provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
| 1 month | +18.79% | 3 years | -53.77% | |
| 3 months | +49.72% | 5 years | -- | |
| 1 year | -29.36% | Since inception | -49.37% |
| Previous close | $36.01 |
| Open day’s range | 34.24 – 38.24 |
| Net asset value (NAV) | 36.16 (12/07/2018) |
| Daily volume | 1,792,130 |
| Average volume (3 months) | 1,709,834 |
| LABD | Category | |
|---|---|---|
| Performance 5-yr return | -- | -29.79% |
| Expense Gross exp ratio | 1.14% | 1.92% |
| Risk 5 year sharpe ratio | -- | -- |
| Net assets | $53.6M | $8.6M |
| Average market cap | -- | -- |
| Average P/E | -- | -- |
| Dividend / Share | -- | 0.35% |
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
| Holdings not available. |
